The 'game-changing' treatment used different human immune cells known as natural killer (NK) cells—with dramatic results.

As a part of our immune defences, cytotoxic T cells – or killer T cells – seek out and destroy cells that are infected or cancerous.

The key to mRNA vaccines appears to be proteins in the pancreatic tumors, which alert the immune system to keep the cancer at bay.

As a part of our immune defences, cytotoxic T cells – or killer T cells – seek out and destroy cells that are infected or cancerous.

The key to these vaccines appears to be neoantigens in the pancreatic tumors, which alert the immune system to keep the cancer at bay.

Albert Einstein College of Medicine research team used different human immune cells known as natural killer (NK) cells with dramatic results

T cells snuggle up to targeted diseased cells and form an intimate junction between the two, called the ‘cytotoxic immunological synapse’.

As a part of our immune defences, cytotoxic T cells – or killer T cells – seek out and destroy cells that are infected or cancerous.

As a part of our immune defences, cytotoxic T cells – or killer T cells – seek out and destroy cells that are infected or cancerous.

The immune system has evolved to safeguard the body from a wildly diverse range of potential threats. Among these are bacterial diseases.

Using cellular “barcoding” in mice, a groundbreaking study finds that blood cells originate not from one type of mother cell, but two.